Abstract
A 48-year-old patient with IgA k multiple myeloma received a BMT from his HLA-matched sibling. After transplantation, the disease relapsed. Melphalan therapy followed by reinfusion of haemopoietic blood stem cells collected from the patient led to the improvement of the clinical status, although mixed chimerism and an elevated serum IgA persisted. Successful donor immunisation against an immunogenic preparation of the recipient monoclonal protein was performed before the infusion of donor T lymphocytes (DLI) into the patient. Ten weeks after the lymphocyte infusions, no monoclonal band was evidenced and donor complete chimerism was detected. The patient did not develop GVHD. Once complete remission was achieved, the idiotype vaccine was administered to the patient. Nineteen months after DLI, the patient remains in remission. Bone Marrow Transplantation (2000) 25, 1105–1108.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Björkstrand B, Ljungman P, Svensson H et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation Blood 1996 88: 4711–4718
Bertz H, Burger JA, Kunzmann R et al. Adoptive immunotherapy for relapsed multiple myeloma after allogenic bone marrow transplantation: evidence for a graft-versus-myeloma effect Leukemia 1997 11: 281–283
Alyea EP, Soiffer RJ, Canning C et al. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant Blood 1998 91: 3671–3680
Lokhorst HM, Schattenberg A, Cornelissen JJ et al. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation Blood 1997 90: 4206–4211
Metha J, Singhal S . Graft-versus-myeloma Bone Marrow Transplant 1998 22: 835–843
Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433–444
Kwak LW, Campbell MJ, Czerwinski DK et al. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors New Engl J Med 1992 327: 1209–1215
Kwak LW, Taub LL, Duffey PL et al. Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor Lancet 1995 345: 1016–1020
Or R, Metha J, Naparstek E et al. Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmocytomas Bone Marrow Transplant 1992 10: 381–382
Zomas A, Stefanoudaki K, Fisfis M et al. Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytomas Bone Marrow Transplant 1998 21: 1163–1165
Acknowledgements
The study was financed by grant No. 97/0963 from the FIS, Spain.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cabrera, R., Díaz-Espada, F., Barrios, Y. et al. Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma. Bone Marrow Transplant 25, 1105–1108 (2000). https://doi.org/10.1038/sj.bmt.1702399
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702399
Keywords
This article is cited by
-
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients
Bone Marrow Transplantation (2013)
-
Immunotherapy in allogeneic hematopoietic stem cell transplantation – not just a case for effector cells
Bone Marrow Transplantation (2005)
-
Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma
Bone Marrow Transplantation (2005)
-
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation
Cancer Immunology, Immunotherapy (2005)
-
Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice
Bone Marrow Transplantation (2001)